GGrantIndex
← Search

Cancer Center Support Grant P30

$3,550,711P30FY2023CANIH

University Of California At Davis, Davis CA

Investigators

Linked publications, trials & patents

Paper 39725713Paper 39620216Paper 39616300Paper 39488208Paper 39453739Paper 39440945Paper 39384967Paper 39383000Paper 39350111Paper 39345479Paper 39345391Paper 39257973Paper 39252929Paper 39217266Paper 39177582Paper 39168154Paper 39108503Paper 39103353Paper 39056190Paper 39046599Paper 39012466Paper 38990223Paper 38979288Paper 38969563Paper 38947002Paper 38885336Paper 38877132Paper 38865710Paper 38843382Paper 38826195Paper 38803393Paper 38798575Paper 38780011Trial NCT07304011Trial NCT07258446Trial NCT07209215Trial NCT07189195Trial NCT07145112Trial NCT06905509Trial NCT06854159Trial NCT06211335Trial NCT06178354Trial NCT06173362Trial NCT06173349Trial NCT06103682Trial NCT06103669Trial NCT06067776Trial NCT05967533Trial NCT05843448Trial NCT05600686Trial NCT05479578Trial NCT05110781Trial NCT05101356Trial NCT05052528Trial NCT04964505Trial NCT04905810Trial NCT04856189Trial NCT04716699Trial NCT04587687Trial NCT04578600Trial NCT04552704Trial NCT04450173Trial NCT04410302Trial NCT04186988Trial NCT04050085Trial NCT04030559Trial NCT03695250Trial NCT03359460Trial NCT03299088Trial NCT03164486Trial NCT03123978Trial NCT02997761Trial NCT02935205Trial NCT02823990Trial NCT02807805Trial NCT02569723Trial NCT02400814Trial NCT02364609Trial NCT02348255Trial NCT02339168Trial NCT02178241Trial NCT02077998Trial NCT01924260Trial NCT01923337Trial NCT01911507Trial NCT01008566Trial NCT00918645Trial NCT00810719Trial NCT00804310Trial NCT00795665Trial NCT00628654Trial NCT00467077Trial NCT00408499Trial NCT00390429Trial NCT00389922Trial NCT00388115Trial NCT00388089Trial NCT00387660Trial NCT00387322Trial NCT00376727

Abstract

PROJECT SUMMARY/ABSTRACT The UC Davis Comprehensive Cancer Center (UCDCCC) is a matrix organization under the aegis of the UC Davis Health and University of California, Davis. It received NCI-designation in 2002 and comprehensive status in 2012. Primo N. Lara, Jr., MD was appointed Cancer Center Director in 2018, overseeing 129 Full Members, five Research Programs, eight Shared Resources, and a robust clinical program. UCDCCC is the only NCI- designated Cancer Center located in the Central Valley of Northern California and thus is best positioned to address the cancer burden of this large geographical region which includes one of the nation’s most productive agricultural regions. UCDCCC aims to leverage the unique resources and strengths of UC Davis to reduce the cancer burden through establishment and promotion of high-impact interdisciplinary cancer-focused research as represented by three Trans-Center Themes: 1) Cancer Risk Mitigation and Early Detection; 2) Innovative Cancer Models and Technologies; and 3) Precision Imaging and Therapy. These themes take advantage of UC Davis’ strengths and expertise in: Human Health Sciences, Veterinary Medicine, Engineering, Agriculture, and Environmental Science. As the region's only academic health center, UC Davis Health encompasses the UC Davis Medical Center, the UC Davis School of Medicine, the Betty Irene Moore School of Nursing, and a distributed system of ambulatory centers. In addition to its nationally ranked NCI-designated UCDCCC, UC Davis is home to the nation’s #1-ranked schools of Veterinary Medicine and Agriculture/Environmental Sciences and is regarded as one of the country’s leading Engineering, Business, and Life Sciences institutions. Seven new Research Initiatives, Tumor-specific Innovation Groups, Disease Team Committees, and other interdisciplinary teams enhance collaborative interactions and proposals with a focus on translating basic and technological findings into team science grants and investigator-initiated trials. The highly diverse catchment area of 19 counties surrounding Sacramento county is benefited through, among other activities, impactful research directed towards the most lethal cancers affecting the area; outreach and engagement efforts to mitigate cancer health disparities and cancer-promoting behaviors; a city-wide early phase clinical trials program; a broad Cancer Care Network through which the resources and expertise of a comprehensive cancer center are brought to disadvantaged and rural areas while keeping patients in their home communities; and the deployment of innovative new technologies such as the world’s most powerful PET scanner EXPLORER, invented by UCDCCC scientists. With renewed and strong institutional commitment and authorities for its Director, UCDCCC is now better positioned than ever before to generate highly impactful discoveries that leverage the unique strengths of one of the nation’s leading public universities to benefit its highly diverse catchment area and beyond.

View original record on NIH RePORTER →